Founded in 2011, Eversept Partners is a New York-based hedge fund manager specializing in an alpha-driven, low-net, fundamentally-oriented, and valuation-disciplined healthcare equity long/short fund. The firm invests across all sub-sectors of healthcare and market caps globally. The investment team employs a fundamental, long-term, valuation-driven research process to select portfolio assets. Portfolio construction focuses on isolating alpha, while risk management processes protect against drawdowns and capital impairment.
Kamran Moghtaderi, the Portfolio Manager, has identified persistent patterns in investor behavior within the complex healthcare sector. These patterns highlight areas of inefficiency and help generate unique long and short-investment ideas. Kamran brings extensive experience from his previous roles at Apis Capital Advisors, LLC, J&W Seligman, and Gambro. Kamran Moghtaderi earned his Master of Business Administration from Harvard Business School, graduating in 2002.
Eversept Partners manages discretionary assets totaling $1,482,568,000 for 7 clients, as reported in their Form ADV dated March 25, 2024. Their most recent 13F filing for Q1 2024 disclosed $1,499,047,038 in managed securities, with a top 10 holdings concentration of 63.32%. The firm's largest holding is Natera Inc, with 1,778,051 shares.